Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
John Rice
AddedMar 31, 2024
UpdatedMay 31, 2026
John Rice

John Rice

Co-Founder, Triathlon Medical Venture Partners

CrunchbaseLinkedIn

John Rice's Career

Triathlon Medical Venture Partners
Triathlon Medical Venture Partners

Cincinnati, OH, US

Co-Founder
Xact Medical
Xact Medical

Cincinnati, OH, US

Board Member· Board
Kereos
Kereos

St. Louis, MO, US

Board Member· Board
Kurome Therapeutics
Kurome Therapeutics

Cincinnati, OH, US

Board Member· Board
Eccrine Systems
Eccrine Systems

Cincinnati, OH, US

Board Member· Board
Airway Therapeutics
Airway Therapeutics

Cincinnati, OH, US

Board Member· Board
Genetesis
Genetesis

Mason, OH, US

Board Member· Board
Enable Injections
Enable Injections

Cincinnati, OH, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

John Rice's Career

Triathlon Medical Venture Partners
Triathlon Medical Venture Partners
Investment FirmInvestment Firm302003Cincinnati, OH, US
Co-Founder

Leadership at Triathlon Medical Venture Partners

Dennis B CostelloDennis B CostelloCo-Founder

Similar to Triathlon Medical Venture Partners

Mediphase Venture PartnersMediphase Venture PartnersNewton, MA, USest. 1999Mediphase Venture PartnersNewton, MA, US · est. 1999

Mediphase Venture Partners: A US-based venture capital firm specializing in healthcare and life sciences.

Investment Firm7
TriStar Health PartnersTriStar Health PartnersNashville, TN, USest. 2009TriStar Health PartnersNashville, TN, US · est. 2009

TriStar Health Partners: A Nashville-based venture capital firm investing in early-stage healthcare innovations since 2009.

Investment Firm2
Triage VenturesTriage VenturesSan Francisco, CA, USTriage VenturesSan Francisco, CA, US

Triage Ventures: A US-based venture capital firm specializing in technology, data, and cloud sectors.

Investment Firm5
Twilight Venture PartnersTwilight Venture PartnersIndianapolis, IN, USest. 2002Twilight Venture PartnersIndianapolis, IN, US · est. 2002

Twilight Venture Partners, LLC: A venture capital firm investing in biotech, healthcare, and related services.

Investment Firm5
Xact Medical
Xact Medical

Cincinnati, OH, US

Board Member· Board
Kereos
Kereos
Series B$27.2M91999St. Louis, MO, US
Board Member· Board

Leadership at Kereos

Gregory LanzaGregory LanzaCo-Founder
Samuel WicklineSamuel WicklineBoard Member
Gary StevensonGary StevensonBoard Member
Greg JohnsonGreg JohnsonBoard Member
Fred M. SchwarzerFred M. SchwarzerBoard Member
Dr Michael D LobergDr Michael D LobergBoard Member

Similar to Kereos

Keros TherapeuticsKeros TherapeuticsLexington, MA, USBiopharmaceuticalsest. 2015Keros TherapeuticsLexington, MA, US · est. 2015

Keros Therapeutics: A global biotech firm innovating treatments for hematological and musculoskeletal disorders.

Public · $230M105
KerafastKerafastBoston, MA, USReagents, Research Toolsest. 2010KerafastBoston, MA, US · est. 2010

Kerafast, Inc.: A leading reagent firm providing laboratory research tools including cell lines, antibodies, and more.

Angel · $3.9M30
KemiaKemiaSan Diego, CA, USPharmaceuticalsest. 2001KemiaSan Diego, CA, US · est. 2001

Discovering therapeutics for inflammation. Serving US healthcare.

Series C · $100M30
Kurome Therapeutics
Kurome Therapeutics
Series A$15M302019Cincinnati, OH, US
Board Member· Board

Leadership at Kurome Therapeutics

Daniel HellerDaniel HellerBoard Member
Jan RosenbaumJan RosenbaumCEO
Daniel StarczynowskiDaniel StarczynowskiBoard Member
Eccrine Systems
Eccrine Systems

Cincinnati, OH, US

Board Member· Board
Airway Therapeutics
Airway Therapeutics
Series C$38.8M122008Cincinnati, OH, US
Board Member· Board

Leadership at Airway Therapeutics

Marc SalzbergMarc SalzbergCEO
Mark CollarMark CollarFounder

Similar to Airway Therapeutics

Aer TherapeuticsAer TherapeuticsRaleigh, NC, USBiopharmaceuticalsest. 2014Aer TherapeuticsRaleigh, NC, US · est. 2014

Aer Therapeutics: Clinical-stage biopharma developing treatments for severe respiratory diseases.

Series A · $36M12
Alveolus BioAlveolus BioBirmingham, AL, USBiotherapeuticsest. 2020Alveolus BioBirmingham, AL, US · est. 2020

Alveolus Bio: Innovating FDA-approved therapeutics for lung diseases.

Series A · $7M7
Genetesis
Genetesis
Series C$35.8M372013Mason, OH, US
Board Member· Board

Leadership at Genetesis

Bill BaumelBill BaumelBoard Member
Manny SetegnManny SetegnCo-Founder
Anil AchyutaAnil AchyutaBoard Member
Mike HoovenMike HoovenBoard Member
Vineet ErasalaVineet ErasalaCo-Founder
Peeyush ShrivastavaPeeyush ShrivastavaCo-Founder
Enable Injections
Enable Injections

Cincinnati, OH, US

Board Member· Board

John Rice's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuHyoung-nyon KimHyoung-nyon KimCo-Founder · Dunamu

People Similar to John Rice

Alberto GomezAlberto GomezCo-Founder · Adara VenturesBrian BirkBrian BirkBoard Member · Sun Mountain CapitalAnthony PhilippakisAnthony PhilippakisBoard Member · Verve TherapeuticsHar GroverHar GroverCo-Founder · GeneTetherTom PetroTom PetroBoard Member · Univest